Provides for enrollment of eligible incarcerated persons in the medical assistance for needy persons program; provides for enrollment of incarcerated individuals in other medical assistance programs, where eligible.
Senate Bill 2113 allows Medicaid accountable care organizations (ACOs) comprised of private physician practices to purchase group health insurance for their members and employees. The bill amends insurance law to create a new category for these specific ACO policies, requiring the organizations to be established for purposes other than just obtaining insurance and to have been active for at least two years. These policies must cover a minimum of 100 individuals at the time of issue and can be funded by the ACO, members, or both. It also exempts qualifying ACO policies from certain small group rating rules, enabling them to access experience-rated health insurance.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
This bill (S 6551) requires health insurance plans in New York to cover image-guided breast biopsies when recommended by a physician based on nationally recognized clinical guidelines. It directly affects patients seeking breast cancer screening and diagnosis, as well as insurance companies that must now include this specific procedure in mandatory coverage. The bill amends insurance law to explicitly add "image-guided breast biopsies" to the list of covered services alongside mammograms, ultrasounds, and MRI scans. Coverage applies only when the procedure aligns with evidence-based guidelines developed by independent medical organizations. The change takes effect January 1, 2026, for all new or renewed insurance policies.
Includes implants, replacement dental prosthetic appliances, crowns and root canals as medically necessary dental care and services for coverage under the Medicaid program if a qualified dentist authorizes the procedures.
This bill removes a specific section from the public health law that previously addressed individuals who knew they had a venereal disease. By repealing this section, the legislation stops the state from enforcing any rules or penalties related to that specific requirement. The change takes effect immediately and prevents any new legal actions from being started under the old rule.
Directs the department of health to create an informational pamphlet concerning intrauterine devices; requires such informational pamphlet to be available on the department of health's website; requires practitioners to distribute such informational pamphlet to patients seeking contraceptives.
Bill S 4612 amends the workers' compensation law to include coverage for treatment provided by licensed massage therapists. It defines "massage therapist" and adds them to the list of authorized healthcare providers within the workers' compensation system. Under this bill, an injured employee can receive massage therapy if prescribed or referred by an authorized physician, physician assistant, podiatrist, or nurse practitioner. Massage therapists rendering such treatment would be required to maintain patient records. However, their reports or opinions would not be considered evidence of the causal link of an injury to a work accident or occupational disease, nor evidence of disability, under this law.
This bill requires New York's Department of Health to create a patient-focused pamphlet about laparoscopic power morcellation surgery by July 1, 2027. The pamphlet must explain the procedure, its risks (including potential cancer spread), benefits, alternatives, required cancer screenings, privacy protections during the procedure, and options for reporting misconduct. It must be written in plain language and available in English plus six common non-English languages spoken in New York. The pamphlet will be provided to patients by healthcare practitioners before they undergo this specific surgery. It directly affects patients considering this procedure and healthcare providers who must offer the pamphlet.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
